Colgate-Palmolive Co acquires a minority stake in Introgen Therapeutics Inc


US - Colgate-Palmolive Co acquired #.##% stake, or #.### mil common shares, in Introgen Therapeutics Inc, a biopharmaceutical company, for $#.### per share, or a total value of $## mil, in a privately negotiated transaction.

Deal Information

Credit & Investment Research

Market Research

News